| Orchestration of ErbB3 signaling through heterointeractions and homointeractions M McCabe Pryor, MP Steinkamp, AM Halasz, Y Chen, S Yang, MS Smith, ... Molecular biology of the cell 26 (22), 4109-4123, 2015 | 30 | 2015 |
| Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling MMC Pryor, ST Low-Nam, ÁM Halász, DS Lidke, BS Wilson, JS Edwards Biophysical journal 105 (6), 1533-1543, 2013 | 23 | 2013 |
| Mathematical simulation of membrane protein clustering for efficient signal transduction K Radhakrishnan, Á Halász, MM McCabe, JS Edwards, BS Wilson Annals of biomedical engineering 40, 2307-2318, 2012 | 23 | 2012 |
| Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level RB Moss, MMC Pryor, R Baillie, K Kudrycki, C Friedrich, M Reed, ... PLoS One 15 (6), e0234683, 2020 | 22 | 2020 |
| Analytical Solution of Steady State Equations for Chemical Reaction Networks with Bilinear Rate Laws. AM Halász, HJ Lai, M McCabe Pryor, K Radhakrishnan, JS Edwards IEEE/ACM transactions on computational biology and bioinformatics/IEEE, ACM, 2013 | 13 | 2013 |
| Spatiotemporal modeling of membrane receptors ÁM Halász, MMC Pryor, BS Wilson, JS Edwards Modeling Cellular Systems, 1-37, 2017 | 3 | 2017 |
| Multiscale modeling of cancer. bioRxiv KA Norton, MMMC Pryor, AS Popel | 2 | 2015 |
| Minimal physiologically-based pharmacokinetic (mPBPK) metamodeling of target engagement in skin informs anti-IL17A drug development in psoriasis VS Ayyar, JB Lee, W Wang, M Pryor, Y Zhuang, T Wilde, A Vermeulen Frontiers in Pharmacology, 1138, 2022 | 1 | 2022 |
| Quantitative Systems Pharmacology Model of the Amyloid Pathway in Alzheimer’s Disease: Insights into the Therapeutic Mechanisms of Clinical Candidates V Ramakrishnan, C Friedrich, C Witt, R Sheehan, M Pryor, JK Atwal, ... CPT: Pharmacometrics & Systems Pharmacology, 2022 | 1 | 2022 |
| Brief Report: Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model RB Moss, MMC Pryor, R Baillie, K Kudrycki, C Friedrich, M Reed, ... | | 2021 |
| USING MECHANISTIC QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODELS TO CONNECT BIOMARKERS TO CLINICAL DISEASE ACTIVITY SCORES-EXAMPLES IN ATOPIC DERMATITIS (AD) AND PSORIASIS (PSO). C Friedrich, R Baillie, M Weis, M Pryor, V Hurez, K Kudrycki, M Reed CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S115-S115, 2020 | | 2020 |
| Quantitative Systems Pharmacology Model to Quantify Benefits of DAAO Inhibition in Schizophrenia S Iadevaia, C Friedrich, M Pryor, C Witt, L Zhang, L Xu, H Faessel, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S103-S104, 2018 | | 2018 |
| Development of a Quantitative Systems Pharmacology (QSP) Model, the Respiratory PhysioPD (TM) Platform, to Investigate Biological Mechanisms Underlying Bronchoconstriction C Friedrich, B Weber, M Pryor, C Witt, J Borghardt, B Disse, C Dallinger, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S16-S17, 2018 | | 2018 |
| Using Mechanistic Physiological Models to Investigate Responder/Non-Responder Attributes Retrospectively and Prospectively to De-Risk Drug Development C Friedrich, M Reed, R Baillie, K Kudrycki, M Weis, M Pryor, D Chung JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S78-S78, 2017 | | 2017 |
| PhysioPD™ Research Enhances Dermatology Research and Drug Development Using Mechanistic Physiological Modeling C Friedrich, K Kudrycki, M Weis, M Pryor, V Hurez, R Baillie, M Reed JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S78-S79, 2017 | | 2017 |
| PhysioPD TM Research Utilizes Mechanistic Physiological Models to Enhance Immunology Research and Drug Development K Kudrycki, M Weis, M Pryor, R Baillie, V Hurez, D Chung, M Reed, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 44, S51-S51, 2017 | | 2017 |
| 717 Mechanistic physiological modeling as a tool for enhancing dermatology research C Friedrich, K Kudrycki, M Weis, M Reed, M Pryor, R Baillie Journal of Investigative Dermatology 137 (5), S123, 2017 | | 2017 |
| A Quantitative Systems Pharmacology Platform of Brain and Serum Progranulin (PGRN) to Investigate Targets in Frontotemporal Dementia (FTD). CM Friedrich, J Soper, CM Witt, MM Pryor, L Martens, D Lee, K Larson, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 43, S15-S15, 2016 | | 2016 |
| Toward a Predictive Model of Spontaneous Clustering of VEGF Receptors E Güven, C Short, MMC Pryor, BS Wilson, JS Edwards, ÁM Halász The Ninth q-bio Conference, 2015 | | 2015 |
| Spatial Stochastic Modeling of the ErbB Receptor Family M Pryor University of New Mexico, 2014 | | 2014 |
Ádám Miklós HalászAssociate Professor of Mathematics, West Virginia UniversityVerified email at math.wvu.edu
